Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

115.76
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
96.18
Today|||52-Week Range
149.34
-5.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues831.0M850.0M893.0M861.0M
 
 
 
 
 
Cost of Goods Sold47.3M50.0M62.0M127.0M
 
 
 
 
 
Depreciation And Amortization100.7M99.0M102.0M110.0M
 
 
 
 
 
 
Operating ExpensesGross Income683.0M701.0M729.0M624.0M
 
 
 
 
 
General Expenses465.0M481.0M464.0M466.0M
 
 
 
 
 
Research And Development206.0M219.0M199.0M195.0M
 
 
 
 
 
Total Operating Expenses613.0M630.0M628.0M703.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income218.0M220.0M265.0M158.0M
 
 
 
 
 
Extraordinary Charge-90.0M-37.0M-58.0M-76.0M
 
 
 
 
 
Interest Expense On Debt25.0M23.0M23.0M25.0M
 
 
 
 
 
Other Expenses-1.0M30.0M18.0M-4.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income104.0M194.0M206.0M58.0M
 
 
 
 
 
Income Taxes-11.0M-24.0M-41.0M-20.0M
 
 
 
 
 
Net Income93.0M170.0M165.0M78.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS225.0M224.0M224.0M223.0M
 
 
 
 
 
Shares To Calculate EPS Diluted226.0M226.0M225.0M225.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.41$0.75$0.73$0.35
 
 
 
 
 
EPS Diluted$0.41$0.75$0.73$0.35